Vigonvita Life Sciences

This early-phase study tests the safety and tolerability of VV119 capsules in 40 people: first in healthy adults, then in patients with schizophrenia. Researchers will monitor side effects and measure drug levels in the blood. The goal is to gather initial safety data before larg…

This study looks at how a standard meal changes the way a new drug, VV119, is processed in the body. It involves 16 healthy Chinese adults who will take the drug once with and without food. The goal is to see if food affects drug levels and to check for any side effects.

This early-stage study tests a single dose of an experimental drug, VV913, in 56 healthy Chinese men aged 18 to 45. The goal is to check how safe the drug is and how the body processes it, not to treat any disease. Participants are randomly assigned to receive either the drug or …

This early-stage study tests a single oral dose of VV261 tablets in 58 healthy adults aged 18-45. The goal is to check safety, side effects, and how the drug moves through the body. Participants are randomly assigned to receive either VV261 or a placebo. This study does not aim t…